Labmox 250mg Capsule contains Amoxycillin 250mg, a broad-spectrum beta-lactam antibiotic belonging to the penicillin class. It is indicated for the treatment of various bacterial infections caused by susceptible strains, including respiratory tract infections, otitis media, skin and soft tissue infections, urinary tract infections, and certain gastrointestinal infections. Amoxycillin exerts its bactericidal action by inhibiting the synthesis of bacterial cell walls, leading to cell lysis and death. Labmox 250mg is effective against a wide range of gram-positive and some gram-negative organisms, including Streptococcus pneumoniae, Haemophilus influenzae, and Escherichia coli. The capsule formulation allows for convenient oral administration with good absorption and bioavailability. Dosage and duration of therapy should be determined based on the severity and type of infection, patient age, weight, and renal function. Common adverse effects include gastrointestinal disturbances such as nausea, vomiting, and diarrhea, as well as hypersensitivity reactions in penicillin-sensitive individuals. Caution is advised in patients with a history of penicillin allergy or mononucleosis. Labmox 250mg should be used as prescribed by a healthcare professional, and the full course of therapy should be completed to prevent resistance development. It is contraindicated in patients with known hypersensitivity to amoxycillin or other beta-lactam antibiotics.